Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacia Nel Mondo Reale di Tofacitinib Sulla Spondiloartropatia Associata Alla Colite Ulcerosa

NCT05431283 is registered in ClinicalTrials.gov with Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) as lead sponsor.

NCT NCT05431283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05431283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacia Nel Mondo Reale di Tofacitinib Sulla Spondiloartropatia Associata Alla Colite Ulcerosa
Lead sponsor
Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
Phase
Observational
Overall status
Unknown status
Start date
April 25, 2022
Completion date
December 31, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spondyloarthropathy, ulcerative colitis